Abstract
Background
In the endoscopic management of unresectable malignant biliary obstructions, covered metallic stents (CMSs) showed longer patency and lower incidence of stent occlusion than uncovered metallic stents (UMCs). However, there are very few reports on factors influencing the results of inserting CMSs. We evaluated differences in clinical results according to stent type.
Methods
We reviewed the results of four types of CMS (polyurethane-covered Diamond stent (PCD), silicone-covered WALLSTENT (SCW), ComVi stent, and VIABIL biliary stent) and an uncovered MS (UMS), based on our experience and the literature. CMSs were characterized according to the axial and radial forces, covering (partial, full), smoothness of the inner surface, and presence of an anti-migration system.
Results
CMSs were patent significantly longer than UMSs. There were differences in stent patency among the CMSs, including the cause of occlusion and other complications. The PCD had good patency and a low incidence of migration. The ComVi stent occluded early due to food impaction, but had the longest median stent patency and a low migration rate. The incidence of migration of SCW was relatively high and the SCW was occluded primarily by sludge.
Conclusions
We should assess the differences between the various CMSs and select the best one for each patient.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Davids PHP, Groen AK, Rauws EAJ, Tytgat GN, Huibregtse K. Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488–92.
Knyrim K, Wagner HJ, Pausch J, Vakil N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy. 1993;25:207–12.
Isayama H, Komatsu Y, Tsujino T, Yoshida H, Tada M, Shiratori Y, et al. Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest Endosc. 2002;55:366–70.
Kubota Y, Mukai H, Nakaizumi A, Tanaka K, Okabe Y, Sakagami T, Kitano M, Mitsufuji S, Shirasaka D, Kikuchi E, Koyama S, Shujiro Y, Shiba M, Yasuda K. Covered Wallstent for palliation of malignant common bile duct stricture: prospective multicenter evaluation. Dig Endosc. 2005;17:218–23.
Kahaleh M, Tokar J, Conaway MR, Brock A, Le T, Adams RB, Yeaton P. Efficacy and complications of covered WALLSTENT in malignant distal biliary obstruction. Gastrointest Endosc. 2005;61:528–33.
Nakai Y, Isayama H, Komatsu Y, Tsujino T, Toda N, Sasahira N, Yamamoto N, Hirano K, Tada M, Yoshida H, Kawabe T, Omata M. Efficacy and safety of covered WALLSTENT in patients with distal malignant biliary obstruction. Gastrointest Endosc. 2005;62:742–8.
Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729–34.
Isayama H, Nakai Y, Toyokawa Y, Togawa O, Gon C, Ito Y, et al. Measurement of radial and axial forces of biliary self-expandable metallic stents. Gastrointest Endosc. 2009;70:37–44.
Telford JJ, Carr-Locke DL, Baron TH, Poneros JM, Bounds BC, Kelsey PB, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72:907–14.
Krokidis M, Fanelli F, Orgera G, Tsetis D, Mouzas I, Bezzi M, et al. Percutaneous palliation of pancreatic head cancer: randomized comparison of ePTFE/FEP-covered versus uncovered Nitinol biliary stents. Cardiovasc Intervent Radiol. 2010;34(2):352–61.
Isayama H, Kawabe T, Nakai Y, Ito Y, Togawa O, Kogure H, Yashima Y, Yagioka H, Matsubara S, Sasaki T, Sasahira N, Hirano K, Tsujino T, Tada M, Omata M. Management of distal malignant biliary obstruction with the ComVi Stent, a new covered metallic stent. Surg Endosc. 2010;24:131–7.
Krokidis M, Fanelli F, Orgera G, Bezzi M, Passariello R, Hatzidakis A. Percutaneous treatment of malignant jaundice due to extrahepatic cholangiocarcinoma: covered VIABIL stent versus uncovered Wallstents. Cardiovasc Intervent Radiol. 2010;33:97–106.
Nakai Y, Isayama H, Togawa O, Kogure H, Tsujino T, Yagioka H, et al. New method of covered WALLSTENT for distal malignant biliary obstruction to reduce early stent-related complications based on characteristics. Dig Endosc. 2011;23:49–55.
Isayama H, Kawabe T, Nakai Y, Komatsu Y, Omata M. Covered metallic stents for the management of distal malignant biliary obstruction. Dig Endosc. 2004;16:S104–6.
Isayama H, Kawabe T, Nakai Y, Tsujino T, Sasahira N, Yamamoto N, et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol. 2006;4:1148–53.
Coté GA, Kumar N, Ansstas M, Edmundowicz SA, Jonnalagadda S, Mullady DK, et al. Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc. 2010;72:748–54.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Isayama, H., Nakai, Y., Kawakubo, K. et al. Covered metallic stenting for malignant distal biliary obstruction: clinical results according to stent type. J Hepatobiliary Pancreat Sci 18, 673–677 (2011). https://doi.org/10.1007/s00534-011-0411-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00534-011-0411-8